183 related articles for article (PubMed ID: 29525983)
1. Identification of novel mutations in FFPE lung adenocarcinomas using DEPArray sorting technology and next-generation sequencing.
Lee JW; Shin JY; Seo JS
J Appl Genet; 2018 Aug; 59(3):269-277. PubMed ID: 29525983
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
[TBL] [Abstract][Full Text] [Related]
3. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
4. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
5. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
Karnes HE; Duncavage EJ; Bernadt CT
Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
[No Abstract] [Full Text] [Related]
8. Challenges in next generation sequencing analysis of somatic mutations in transplant patients.
Chen H; Luthra R; Patel KP; Routbort M; Rashid A; Roy-Chowdhuri S; Lazar A; Broaddus R; Manekia J; Singh RR; Yemelyanova A
Cancer Genet; 2018 Oct; 226-227():17-22. PubMed ID: 30005850
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.
Maru Y; Tanaka N; Ohira M; Itami M; Hippo Y; Nagase H
Gynecol Oncol; 2017 Feb; 144(2):377-383. PubMed ID: 27939411
[TBL] [Abstract][Full Text] [Related]
10. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
11. Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.
Bolognesi C; Forcato C; Buson G; Fontana F; Mangano C; Doffini A; Sero V; Lanzellotto R; Signorini G; Calanca A; Sergio M; Romano R; Gianni S; Medoro G; Giorgini G; Morreau H; Barberis M; Corver WE; Manaresi N
Sci Rep; 2016 Feb; 6():20944. PubMed ID: 26864208
[TBL] [Abstract][Full Text] [Related]
12. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
14. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.
Chevrier S; Arnould L; Ghiringhelli F; Coudert B; Fumoleau P; Boidot R
Int J Oncol; 2014 Sep; 45(3):1167-74. PubMed ID: 24990411
[TBL] [Abstract][Full Text] [Related]
16. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
17. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
[TBL] [Abstract][Full Text] [Related]
18. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.
Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G
Oncotarget; 2015 May; 6(14):12783-95. PubMed ID: 25904052
[TBL] [Abstract][Full Text] [Related]
20. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
